Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by BioNTech SE < Previous 1 2 Next > BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024 Today 11:15 EDT From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech Announces First Quarter 2024 Financial Results and Corporate Update May 06, 2024 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024 April 22, 2024 From BioNTech SE Via GlobeNewswire Tickers BNTX Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer April 07, 2024 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update March 20, 2024 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer March 20, 2024 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024 March 11, 2024 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech Announces Planned Retirement of Sean Marett March 07, 2024 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024 March 06, 2024 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs February 08, 2024 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305 January 31, 2024 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer January 22, 2024 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference January 09, 2024 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Endometrial Cancer December 21, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda December 18, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech to Inaugurate First African Site on December 18, 2023 December 12, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update November 06, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19 October 26, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023 October 23, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to Host Innovation Series Day on November 7, 2023 October 23, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech Expands Late-Stage Clinical Oncology Portfolio with Initiation of further Phase 2 Trial with mRNA-based Individualized Neoantigen Specific Immunotherapy in New Cancer Indication October 19, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023 October 16, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs October 16, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine September 28, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission September 18, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union August 30, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer August 14, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update August 07, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech Completes Acquisition of InstaDeep July 31, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX BioNTech to Report Second Quarter 2023 Financial Results and Operational Update on August 7, 2023 July 24, 2023 From BioNTech SE Via GlobeNewswire Tickers BNTX < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.